Alferiev IS, Guerrero DT, Guan P, Nguyen F, Kolla V, Soberman D, Pressly BB, Fishbein I, Brodeur GM. Chorny M.Poloxamer-linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high-risk neuroblastoma with primary and acquired chemoresistance. FASEB J. 2022 Mar;36(3):e22213.

Uemura S, Lin KS, Mon Thwin KK, Nakatani N, Ishida T, Yamamoto N, Tamura A, Saito A, Mori T, Hasegawa D, Kosaka Y, Nino N, Nagano C, Takafuji S, Iijima K, Nishimura N. Limited correlation between tumor markers and minimal residual disease detected by seven neuroblastoma-associated mRNAs in high-risk neuroblastoma patients. Mol Clin Oncol. 2021 Jul;15(1):137.

Hochheuser C, van Zogchel LMJ, Kleijer M, Kuijk C, Tol S, van der Schoot CE, Voermans C, Tytgat GAM, Timmerman I. The Metastatic Bone Marrow Niche in Neuroblastoma: Altered Phenotype and Function of Mesenchymal Stromal Cells. Cancers (Basel) 2020 Nov 2;12(11):3231.

Körholz K, Ridinger J, Krunic D, Najafi S, Gerloff XF, Frese K, Meder B, Peterziel H, Vega-Rubin-de-Celis S, Witt O, Oehme I. Broad-Spectrum HDAC Inhibitors Promote Autophagy through FOXO Transcription Factors in Neuroblastoma.Cells 2021 Apr 24;10(5):1001.

Aygun N. Biological and genetic features of Neuroblastoma and their clinical importance. Curr Pediatr Rev. 2018;14(2):73–90.

Article  CAS  PubMed  Google Scholar 

Otsuka K, Sasada M, Iyoda T, Nohara Y, Sakai S, Asayama T, Suenaga Y, Yokoi S, Higami Y, Kodama H. Fukai F.Combining peptide TNIIIA2 with all-trans retinoic acid accelerates N-Myc protein degradation and neuronal differentiation in MYCN-amplified neuroblastoma cells. Am J Cancer Res 2019 Feb 1;9(2):434–448.

Nosrat CA, MacCallum DK, Mistretta CM. Distinctive spatiotemporal expression patterns for neurotrophins develop in gustatory papillae and lingual tissues in embryonic tongue organ cultures. Cell Tissue Res. 2001 Jan;303(1):35–45.

Serafim Junior V, Fernandes GMM, Oliveira-Cucolo JG, Pavarino EC, Goloni-Bertollo EM. Role of tropomyosin-related kinase B receptor and brain-derived neurotrophic factor in cancer.Cytokine. 2020 Dec;136:155270.

Li T, Yu Y, Song Y, Li X, Lan D, Zhang P, Xiao Y, Xing Y. Activation of BDNF/TrkB pathway promotes prostate cancer progression via induction of epithelial-mesenchymal transition and anoikis resistance. FASEB J. 2020 Jul;34(7):9087–101.

Yuan Y, Ye HQ, Ren QC. Proliferative role of BDNF/TrkB signaling is associated with anoikis resistance in cervical cancer.Oncol Rep 2018 Aug;40(2):621–34.

Colucci-D’Amato L, Speranza L, Volpicelli FNeurotrophic, Factor BDNF. Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer.Int J Mol Sci 2020 Oct 21;21(20):7777.

D’Angelo B, Benedetti E, Di Loreto S, Cristiano L, Laurenti G, Cerù MP, Cimini A. Signal transduction pathways involved in PPARβ/δ-induced neuronal differentiation. J Cell Physiol. 2011 Aug;226(8):2170–80.

Hua Z, Zhan Y, Zhang S, Dong Y, Jiang M, Tan F, Liu Z, Thiele CJ, Li Z. P53/PUMA are potential targets that mediate the protection of brain-derived neurotrophic factor (BDNF)/TrkB from etoposide-induced cell death in neuroblastoma (NB).Apoptosis 2018 Aug;23(7–8):408–419.

Ohnishi T, Sakamoto K, Asami-Odaka A, Nakamura K, Shimizu A, Ito T, Asami T, Ohtaki T, Inooka H. Generation of a novel artificial TrkB agonist, BM17d99, using T7 phage-displayed random peptide libraries.Biochem Biophys Res Commun 2017 Jan 29;483(1):101–6.

Zheng H, Niu S, Zhao H, Li S, Jiao J. Donepezil improves the cognitive impairment in a tree shrew model of Alzheimer’s disease induced by amyloid-β1–40 via activating the BDNF/TrkB signal pathway. Metab Brain Dis. 2018 Dec;33(6):1961–74.

Xiong X, Li Y, Liu L, Qi K, Zhang C, Chen Y, Fang J. Arsenic trioxide induces cell cycle arrest and affects trk receptor expression in human neuroblastoma SK-N-SH cells.Biol res 2018 Jun 13;51(1):18.

Feng X, Jiang H, Baik JC, Edgar C. Eide FF.BDNF dependence in neuroblastoma.J Neurosci Res 2001 May 15;64(4):355–63.

Li C, Peng X, Feng C, Xiong X, Li J, Liao N, Yang Z, Liu A, Wu P, Liang X, He Y, Tian X, Lin Y, Wang S, Li Y. Excellent Early Outcomes of Combined Chemotherapy With Arsenic Trioxide for Stage 4/M Neuroblastoma in Children: A Multicenter Nonrandomized Controlled Trial.Oncol Res 2021 Sep 7;28(7):791–800.

Brodeur. GM.Spontaneous regression of neuroblastoma.Cell Tissue Res. 2018 May;372(2):277–286.

Tomolonis JA, Agarwal S, Shohet JM. Neuroblastoma pathogenesis: deregulation of embryonic neural crest development. Cell Tissue Res. 2018 May;372(2):245–62.

Brodeur GM, Bagatell R. Mechanisms of neuroblastoma regression. Nat Rev Clin Oncol. 2014 Dec;11(12):704–13.

Nakagawara A, Azar CG, Scavarda NJ, Brodeur GM. Expression and function of TRK-B and BDNF in human neuroblastomas. Mol Cell Biol. 1994 Jan;14(1):759–67.

Passaro A, Dalla Nora E, Morieri ML, Soavi C, Sanz JM, Zurlo A, Fellin R, Zuliani G. Brain-derived neurotrophic factor plasma levels: relationship with dementia and diabetes in the elderly population.J Gerontol A Biol. Sci Med Sci. 2015 Mar;70(3):294–302.

Carroll AP, Tooney PA, Cairns MJ. Design and interpretation of microRNA-reporter gene activity.Anal Biochem 2013 Jun 15;437(2):164–71.

Aygun N. Biological and genetic features of Neuroblastoma and their clinical importance. Curr Pediatr Rev. 2018;14(2):73–90.

Article  CAS  PubMed  Google Scholar 

Cervantes-Villagrana RD, Albores-García D, Cervantes-Villagrana AR, García-Acevez SJ. Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies.Signal Transduct Target Ther 2020 Jun 18;5(1):99.

Crosstalk. between EGFR and TrkB enhances ovarian cancer cell migration and proliferation. Int. J. Oncol. 2006;29:1003–1011.

Wang P, Wan W, Xiong S, Wang J, Zou D, Lan C. Wu N. HIF1α regulates glioma chemosensitivity through the transformation between differentiation and dedifferentiation in various oxygen levels. Sci Rep. 2017;7:7965.

Article  PubMed  PubMed Central  Google Scholar 

Lim JY, Park SI, Kim SM, Jun JA, Oh JH, Ryu CH, Jeong CH, Park SH, Park SA, Oh W, Chang JW, Jeun SS. Neural differentiation of brain-derived neurotrophic factor-expressing human umbilical cord blood-derived mesenchymal stem cells in culture via TrkB-mediated ERK and β-catenin phosphorylation and following transplantation into the developing brain. Cell Transpl. 2011;20(11–12):1855–66.

Article  Google Scholar 

Buchman AS, Yu L, Boyle PA, Schneider JA, De Jager PL. Bennett DA.Higher brain BDNF gene expression is associated with slower cognitive decline in older adults. Neurology 2016 Feb 23;86(8):735 – 41.

Light JE, Koyama H, Minturn JE, Ho R, Simpson AM, Iyer R, Mangino JL, Kolla V, London WB. Brodeur GM.Clinical significance of NTRK family gene expression in neuroblastomas. Pediatr Blood Cancer. 2012 Aug;59(2):226–32.

Zhang HY, Xing MQ, Guo J, Zhao JC, Chen X, Jiang Z, Zhang H, Dong Q. Long noncoding RNA DLX6-AS1 promotes neuroblastoma progression by regulating miR-107/BDNF pathway.Cancer Cell Int 2019 Nov 27;19:313.

Chen B, Liang Y, He Z, An Y, Zhao W, Wu J. Autocrine activity of BDNF induced by the STAT3 signaling pathway causes prolonged TrkB activation and promotes human non-small-cell lung cancer proliferation Sci Rep 2016 Jul 26;6:30404.

Desai AV, Applebaum MA, Karrison TG, Oppong A, Yuan C, Berg KR, MacQuarrie K, Sokol E, Hall AG, Pinto N, Wolfe I, Mody R, Shusterman S, Smith V, Foster JH, Nassin M, LaBelle JL, Bagatell R, Cohn SL. Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease. Cancer. 2022 Aug 1;128(15):2967–2977.

Seemann NM, Erker C, Irwin MS, Lopushinsky SR, Kulkarni K, Fernandez CV, Romao RLP. Survival effect of complete surgical resection of the primary tumor in patients with metastatic, high-risk neuroblastoma in a large canadian cohort. Pediatr Blood Cancer. 2023 Jun;70(6):e30286.

Furman WL, McCarville B, Shulkin BL, Davidoff A, Krasin M, Hsu CW, Pan H, Wu J, Brennan R, Bishop MW, Helmig S, Stewart E, Navid F, Triplett B, Santana V, Santiago T, Hank JA, Gillies SD, Yu A, Sondel PM, Leung WH, Pappo A, Federico SM. Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A. J Clin Oncol. 2022 Feb 1;40(4):335–344.

DuBois SG, Macy ME, Henderson TO. High-risk and relapsed neuroblastoma: toward more cures and better Outcomes.Am soc clin oncol Educ Book. 2022 Apr;42:1–13.

Zou W, Hu X, Jiang L. Advances in regulating tumorigenicity and metastasis of Cancer through TrkB signaling. Curr Cancer Drug Targets. 2020;20(10):779–88.

Article  CAS  PubMed  Google Scholar 

Yang X, Martin TA, Jiang WG. Biological influence of brain-derived neurotrophic factor on breast cancer cells. Int J Oncol. 2012 Oct;41(4):1541–6.

Moraes JK, Wagner VP, Fonseca FP, Amaral-Silva GKD, de Farias CB, Pilar EFS, Gregianin L, Roesler R, Vargas PA. Martins MD.Activation of BDNF/TrkB/Akt pathway is associated with aggressiveness and unfavorable survival in oral squamous cell carcinoma. Oral Dis. 2019 Nov;25(8):1925–36.

Morita K, Lee MS, Her S. Possible relation of hemin-induced HO-1 expression to the upregulation of VEGF and BDNF mRNA levels in rat C6 glioma cells. J Mol Neurosci. 2009 May;38(1):31–40.

Czarnecka M, Trinh E, Lu C, Kuan-Celarier A, Galli S, Hong SH, Tilan JU, Talisman N, Izycka-Swieszewska E, Tsuei J, Yang C, Martin S, Horton M, Christian D, Everhart L, Maheswaran I, Kitlinska J. Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.Oncogene 2015 Jun 11;34(24):3131-43.

Szudy-Szczyrek A, Mlak R, Bury-Kamińska M, Mielnik M, Podgajna M, Kuśmierczuk K, Mazurek M, Homa-Mlak I, Szczyrek M, Krawczyk J, Małecka-Massalska T. Hus M.Serum brain-derived neurotrophic factor (BDNF) concentration predicts polyneuropathy and overall survival in multiple myeloma patients. Br J Haematol. 2020 Oct;191(1):77–89.